{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:27:47Z","timestamp":1784921267467,"version":"3.55.0"},"reference-count":35,"publisher":"The Endocrine Society","issue":"1","funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["UL1 TR000135"],"award-info":[{"award-number":["UL1 TR000135"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK116231"],"award-info":[{"award-number":["DK116231"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK78646"],"award-info":[{"award-number":["DK78646"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Abnormal glucagon concentrations contribute to hyperglycemia, but the mechanisms of \u03b1-cell dysfunction in prediabetes are unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We sought to determine the relative contributions of insulin secretion and action to \u03b1-cell dysfunction in nondiabetic participants across the spectrum of glucose tolerance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>This was a cross-sectional study. A subset of participants (n = 120) was studied in the presence and absence of free fatty acid (FFA) elevation, achieved by infusion of Intralipid (Baxter Healthcare, Deerfield, IL) plus heparin, to cause insulin resistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>An inpatient clinical research unit at an academic medical center.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>A total of 310 nondiabetic persons participated in this study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>Participants underwent a seven-sample oral glucose tolerance test. Subsequently, 120 participants were studied on two occasions. On one day, infusion of Intralipid plus heparin raised FFA. On the other day, participants received glycerol as a control.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure(s)<\/jats:title>\n                  <jats:p>We examined the relationship of glucagon concentration with indices of insulin action after adjusting for the effects of age, sex, and weight. Subsequently, we sought to determine whether an acute decrease in insulin action, produced by FFA elevation, altered glucagon concentrations in nondiabetic participants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fasting glucagon concentrations correlated positively with fasting insulin and C-peptide concentrations and inversely with insulin action. Fasting glucagon was not associated with any index of \u03b2-cell function in response to an oral challenge. As expected, FFA elevation decreased insulin action and also raised glucagon concentrations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In nondiabetic participants, glucagon secretion was altered by changes in insulin action.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2017-01197","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T19:07:15Z","timestamp":1509995235000},"page":"314-319","source":"Crossref","is-referenced-by-count":34,"title":["Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans"],"prefix":"10.1210","volume":"103","author":[{"given":"Anu","family":"Sharma","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T","family":"Varghese","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Dalla","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Information Engineering, Universit\u00e0 di Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cobelli","sequence":"additional","affiliation":[{"name":"Department of Information Engineering, Universit\u00e0 di Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Rizza","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent R","family":"Bailey","sequence":"additional","affiliation":[{"name":"Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Vella","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"issue":"7897","key":"2020071621343169900_B1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(75)92375-2","article-title":"The essential role of glucagon in the pathogenesis of diabetes mellitus","volume":"1","author":"Unger","year":"1975","journal-title":"Lancet"},{"issue":"2 Pt 1","key":"2020071621343169900_B2","first-page":"E283","article-title":"Impact of lack of suppression of glucagon on glucose tolerance in humans","volume":"277","author":"Shah","year":"1999","journal-title":"Am J Physiol"},{"issue":"11","key":"2020071621343169900_B3","first-page":"4053","article-title":"Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus","volume":"85","author":"Shah","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071621343169900_B4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF01236318","article-title":"The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile type diabetes","volume":"13","author":"Aydin","year":"1977","journal-title":"Diabetologia"},{"issue":"2","key":"2020071621343169900_B5","doi-asserted-by":"crossref","first-page":"E401","DOI":"10.1152\/ajpendo.00674.2007","article-title":"The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance","volume":"295","author":"Abdul-Ghani","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"2020071621343169900_B6","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.2337\/db06-0319","article-title":"Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and\/or impaired glucose tolerance","volume":"55","author":"Bock","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"2020071621343169900_B7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/JOE-08-0290","article-title":"Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes","volume":"199","author":"Quesada","year":"2008","journal-title":"J Endocrinol"},{"issue":"6","key":"2020071621343169900_B8","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1172\/JCI111658","article-title":"Insulin within islets is a physiologic glucagon release inhibitor","volume":"74","author":"Maruyama","year":"1984","journal-title":"J Clin Invest"},{"issue":"4","key":"2020071621343169900_B9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cmet.2009.02.007","article-title":"Insulin signaling in alpha cells modulates glucagon secretion in vivo","volume":"9","author":"Kawamori","year":"2009","journal-title":"Cell Metab"},{"issue":"6","key":"2020071621343169900_B10","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2337\/diabetes.54.6.1808","article-title":"Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release","volume":"54","author":"Franklin","year":"2005","journal-title":"Diabetes"},{"issue":"4","key":"2020071621343169900_B11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2337\/diabetes.53.4.1038","article-title":"Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells","volume":"53","author":"Wendt","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"2020071621343169900_B12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/db08-0792","article-title":"Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function","volume":"58","author":"Hauge-Evans","year":"2009","journal-title":"Diabetes"},{"issue":"8","key":"2020071621343169900_B13","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.2337\/db13-1371","article-title":"Control of insulin secretion by cholinergic signaling in the human pancreatic islet","volume":"63","author":"Molina","year":"2014","journal-title":"Diabetes"},{"issue":"6","key":"2020071621343169900_B14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cmet.2010.04.007","article-title":"GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis","volume":"11","author":"De Marinis","year":"2010","journal-title":"Cell Metab"},{"issue":"11","key":"2020071621343169900_B15","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s001250100003","article-title":"Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations","volume":"44","author":"Ahr\u00e9n","year":"2001","journal-title":"Diabetologia"},{"issue":"4","key":"2020071621343169900_B16","doi-asserted-by":"crossref","first-page":"E832","DOI":"10.1152\/ajpendo.00700.2009","article-title":"Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes","volume":"298","author":"Hare","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"2020071621343169900_B17","doi-asserted-by":"crossref","first-page":"E1038","DOI":"10.1152\/ajpendo.00665.2010","article-title":"The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes","volume":"300","author":"Lund","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"2020071621343169900_B18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00125-006-0566-z","article-title":"Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus","volume":"50","author":"Knop","year":"2007","journal-title":"Diabetologia"},{"issue":"11","key":"2020071621343169900_B19","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.2337\/db16-0240","article-title":"Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation","volume":"65","author":"F\u00e6rch","year":"2016","journal-title":"Diabetes"},{"issue":"11","key":"2020071621343169900_B20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/M15-2345","article-title":"Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement","volume":"163","author":"Siu","year":"2015","journal-title":"Ann Intern Med"},{"issue":"7","key":"2020071621343169900_B21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc15-1643","article-title":"Evaluation of efficacy and safety of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes: 12- and 24-week phase 2 studies","volume":"39","author":"Kazda","year":"2016","journal-title":"Diabetes Care"},{"issue":"2","key":"2020071621343169900_B22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2265.2011.04159.x","article-title":"A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations","volume":"76","author":"Sathananthan","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071621343169900_B23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2337\/db15-1233","article-title":"TCF7L2 Genotype and \u03b1-cell function in humans without diabetes","volume":"65","author":"Shah","year":"2016","journal-title":"Diabetes"},{"issue":"2","key":"2020071621343169900_B24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jc.2011-2561","article-title":"Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes","volume":"97","author":"Smushkin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071621343169900_B25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/diabetes.51.2.301","article-title":"Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans","volume":"51","author":"Shah","year":"2002","journal-title":"Diabetes"},{"issue":"11","key":"2020071621343169900_B26","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.2337\/diabetes.54.11.3265","article-title":"Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals","volume":"54","author":"Dalla Man","year":"2005","journal-title":"Diabetes"},{"issue":"3","key":"2020071621343169900_B27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"issue":"4","key":"2020071621343169900_B28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/db13-1198","article-title":"The oral minimal model method","volume":"63","author":"Cobelli","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"2020071621343169900_B29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2337\/diab.40.1.73","article-title":"Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients","volume":"40","author":"Butler","year":"1991","journal-title":"Diabetes"},{"issue":"2","key":"2020071621343169900_B30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00125-013-3121-8","article-title":"HOMA and Matsuda indices of insulin sensitivity: poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings","volume":"57","author":"Xiang","year":"2014","journal-title":"Diabetologia"},{"issue":"36","key":"2020071621343169900_B31","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1073\/pnas.1409638111","article-title":"Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells","volume":"111","author":"Lee","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020071621343169900_B32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","article-title":"Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study","volume":"47","author":"Gastaldelli","year":"2004","journal-title":"Diabetologia"},{"issue":"1","key":"2020071621343169900_B33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/jc.2004-1133","article-title":"beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis","volume":"90","author":"Ferrannini","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071621343169900_B34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2337\/db07-1124","article-title":"Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance","volume":"57","author":"Vollmer","year":"2008","journal-title":"Diabetes"},{"issue":"4","key":"2020071621343169900_B35","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2337\/db15-1593","article-title":"Diabetes-Associated Variation in TCF7L2 Is Not Associated With Hepatic or Extrahepatic Insulin Resistance","volume":"65","author":"Varghese","year":"2016","journal-title":"Diabetes"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/1\/314\/23270164\/jc.2017-01197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/1\/314\/23270164\/jc.2017-01197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T09:16:24Z","timestamp":1594977384000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/1\/314\/4590235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-01197","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,11,6]]}}}